These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25680099)

  • 1. Nanocarriers in therapy of infectious and inflammatory diseases.
    Ikoba U; Peng H; Li H; Miller C; Yu C; Wang Q
    Nanoscale; 2015 Mar; 7(10):4291-305. PubMed ID: 25680099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in targeted nanoparticles drug delivery to melanoma.
    Li J; Wang Y; Liang R; An X; Wang K; Shen G; Tu Y; Zhu J; Tao J
    Nanomedicine; 2015 Apr; 11(3):769-94. PubMed ID: 25555352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of site-specific drug delivery nanocarriers based on receptor mediation.
    Wang X; Li S; Shi Y; Chuan X; Li J; Zhong T; Zhang H; Dai W; He B; Zhang Q
    J Control Release; 2014 Nov; 193():139-53. PubMed ID: 24862317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery nanoparticles in skin cancers.
    Dianzani C; Zara GP; Maina G; Pettazzoni P; Pizzimenti S; Rossi F; Gigliotti CL; Ciamporcero ES; Daga M; Barrera G
    Biomed Res Int; 2014; 2014():895986. PubMed ID: 25101298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation.
    Nagar N; Naidu G; Mishra A; Poluri KM
    J Pharmacol Exp Ther; 2024 Jan; 388(1):91-109. PubMed ID: 37699711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology controlled drug delivery for treating bone diseases.
    Yang L; Webster TJ
    Expert Opin Drug Deliv; 2009 Aug; 6(8):851-64. PubMed ID: 19637973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nanoscale drug carriers for traditional Chinese medicine research and development].
    Yi CX; Yu JN; Xu XM
    Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):1936-40. PubMed ID: 19086622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical and biomedical applications of lipid-based nanocarriers.
    Carbone C; Leonardi A; Cupri S; Puglisi G; Pignatello R
    Pharm Pat Anal; 2014 Mar; 3(2):199-215. PubMed ID: 24588596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface.
    Behzadi S; Serpooshan V; Sakhtianchi R; Müller B; Landfester K; Crespy D; Mahmoudi M
    Colloids Surf B Biointerfaces; 2014 Nov; 123():143-9. PubMed ID: 25262409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respirable nanocarriers as a promising strategy for antitubercular drug delivery.
    Mehanna MM; Mohyeldin SM; Elgindy NA
    J Control Release; 2014 Aug; 187():183-97. PubMed ID: 24878180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nanoscale tailoring of the surface properties of biomaterials and drug carriers].
    Järvinen K; Jokiniemi J; Lammi M; Lappalainen R; Närvänen A; Pakkanen TA; Lehto VP
    Duodecim; 2012; 128(20):2085-92. PubMed ID: 23167167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nanotechnology in HIV/AIDS treatment: potential to overcome the viral reservoir challenge.
    Amiji MM; Vyas TK; Shah LK
    Discov Med; 2006 Aug; 6(34):157-62. PubMed ID: 17234137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition.
    Agarwal R; Roy K
    Ther Deliv; 2013 Jun; 4(6):705-23. PubMed ID: 23738668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced nanocarriers based on heparin and its derivatives for cancer management.
    Yang X; Du H; Liu J; Zhai G
    Biomacromolecules; 2015 Feb; 16(2):423-36. PubMed ID: 25517794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology approaches for global infectious diseases.
    Kirtane AR; Verma M; Karandikar P; Furin J; Langer R; Traverso G
    Nat Nanotechnol; 2021 Apr; 16(4):369-384. PubMed ID: 33753915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology applied to the treatment of malaria.
    Santos-Magalhães NS; Mosqueira VC
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanodevices that acts as nanocarriers for controlled and directed drug delivery to select cells, organs or tissues in cardiovascular diseases.
    Vélez-Reséndiz JM; Vélez-Arvízu JJ
    Gac Med Mex; 2017; 153(3):354-360. PubMed ID: 28763074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.